For the year ending 2025-12-31, NVCR made $655,353K in revenue. -$136,227K in net income. Net profit margin of -20.79%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Net revenues | 655,353 | 605,220 | ||
| Cost of revenues | 166,879 | 137,181 | ||
| Gross profit | 488,474 | 468,039 | ||
| Research, development and clinical studies | 224,544 | 209,645 | ||
| Sales and marketing | 240,064 | 239,063 | ||
| General and administrative | 177,666 | 189,827 | ||
| Total operating costs and expenses | 642,274 | 638,535 | ||
| Operating income (loss) | -153,800 | -170,496 | ||
| Financial (expenses) income, net | 17,550 | 39,334 | ||
| Total income (loss) before income taxes | -136,250 | -131,162 | ||
| Income tax | -23 | 37,465 | ||
| Net income (loss) | -136,227 | -168,627 | ||
| Basic EPS | -1.22 | -1.56 | ||
| Diluted EPS | -1.22 | -1.56 | ||
| Basic Average Shares | 111,471,991 | 107,834,368 | ||
| Diluted Average Shares | 111,471,991 | 107,834,368 | ||
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)